An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors
Clinical trial NCT02488759 · COMPLETED
Trial details
- NCT number
- NCT02488759
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-13
- Primary completion
- 2021-03-19
- Enrollment
- 578
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.